Results 131 to 140 of about 77,929 (279)

METHODS AND TECHNIQUES IN RECOVERING PATIENTS OF ANKYLOSING SPONDYLITIS [PDF]

open access: yesAnnals of the “Ştefan cel Mare” University: Physical Education and Sport Section - The Science and Art of Movement, 2018
Ankylosing spondylitis starts at the sacroiliac joint, affecting in a progressive way the spine’s joints, causing incorrect body postures and respiratory complications.
Andreea Domnica Buburuzan   +1 more
doaj  

Elevated Serum Proadrenomedullin Levels in Rheumatoid Arthritis Versus Spondyloarthritis: Insights From a Biobank Cohort

open access: yesACR Open Rheumatology, Volume 8, Issue 5, May 2026.
Objective Proadrenomedullin (pro‐ADM) is a peptide implicated in immunomodulation, with higher levels observed in inflammatory conditions, cardiovascular impairment, and sepsis. Although extensively studied in acute disorders, its potential as a biomarker in inflammatory arthritis remains underexplored.
Nefeli Stavroula Papastathopoulou   +10 more
wiley   +1 more source

Can Dixon technique replace conventional magnetic resonance imaging for precise assessment of sacroiliitis in ankylosing spondylitis patients?

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine
Background Ankylosing spondylitis (AS) is a subtype of arthritis from the axial spondylarthritis spectrum. Involvement of the sacroiliac joints is regarded as an early indicator of ankylosing spondylitis (AS), enabling early detection, and effective ...
Suzan Omar   +2 more
doaj   +1 more source

Plasma Proteomics Identifies Thousand‐and‐One–Amino Acid Kinase 3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target

open access: yesArthritis &Rheumatology, Volume 78, Issue 5, Page 1045-1061, May 2026.
Objective Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted
Pengfei Xin   +15 more
wiley   +1 more source

Withdrawn: Impact of the RNF123 mutation on osteoclast differentiation in familial ankylosing spondylitis

open access: yesRheumatology &Autoimmunity, EarlyView.
Jin S, Ji X, Zhang L, Shi Y, Zhao D, Wan W. Impact of the RNF123 mutation on osteoclast differentiation in familial ankylosing spondylitis. Rheumatol & Autoimmun. 2023;1‐8. doi:10.1002/rai2.12102 Withdrawal: The above article, first published online 11th September 2024, on Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement ...
wiley   +1 more source

Spondyloarthritis Associated With Collagenous Colitis—Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Collagenous colitis (CC) is a subtype of microscopic colitis characterized by chronic watery diarrhea with normal endoscopic findings. Although often linked to autoimmune diseases, its association with spondyloarthropathy (SpA) is rare and poorly documented.
Charlotte Bouvy   +4 more
wiley   +1 more source

Morphea Induced by Golimumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Morphea is a localized autoimmune fibrosing disorder that may paradoxically develop during anti‐TNFα agents in ankylosing spondylitis (AS). We report a second case of morphea associated with long‐term golimumab use in a patient with AS, presenting with indurated plaques and confirmed histopathologically.
Faten Hilwanjee   +3 more
wiley   +1 more source

Association Between Disease Activity and C-reactive Protein to Serum Albumin Ratio in Patients with Ankylosing Spondylitis

open access: yesAdvanced Medical Journal
Background and objectives: Ankylosing spondylitis is a persistent inflammatory rheumatic condition that predominantly affects the axial skeleton. The current research aims to assess the correlation between disease activity and the C-reactive protein to ...
Avin Mariwan Mohammed Saleh   +1 more
doaj   +1 more source

Targeting of Gut Microbiota by Bioactive Peptides for the Improvement of Metabolic Diseases: A Review

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
Bioactive peptides (BPs) derived from dietary proteins modulate the gut microbiotametabolism axis by reshaping microbial composition and regulating key metabolites, including short‐chain fatty acids. BPs also enhance intestinal barrier integrity and immune homeostasis, thereby reducing inflammation.
Jiao Li   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy